If you are experiencing this alongside stalled progress, check our guide on why weight loss stalls on tirzepatide for additional factors that may be contributing
Hahn AW, Menk AV, Rivadeneira DB, Augustin RC, Xu M, Li J, Wu X, Mishra AK, Gide TN, Quek C, Zang Y, Spencer CN, Menzies AM, Daniel CR, Hudgens CW, Nowicki T, Haydu LE, Khan MAW, Gopalakrishnan V, Burton EM, Malke J, Simon JM, Bernatchez C, Putluri N, Woodman SE, Vashisht Gopal YN, Guerrieri R, Fischer GM, Wang J, Wani KM, Thompson JF, Lee JE, Hwu P, Ajami N, Gershenwald JE, Long GV, Scolyer RA, Tetzlaff MT, Lazar AJ, Schadendorf D, Wargo JA, Kirkwood JM, DeBerardinis RJ, Liang H, Futreal A, Zhang J, Wilmott JS, Peng W, Davies MA , Delgoffe GM, Najjar YG, McQuade JL
Its production cost and price are also key to determining whether the drug can be used by American insurers and the European health care system
However, after seeing how it also led to weight loss, researchers began to study it for weight management
2009;11(s4):159167
Even plans that include Wegovy for obesity management typically require prior authorization, a BMI threshold, and documentation of previous weight loss attempts